BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND XPA, XPAC, 7507, ENSG00000136936, XP1, P23025
28 results:

  • 1. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal cancer: A Systematic Review and Meta-Analysis.
    Liao CK; Kuo YT; Lin YC; Chern YJ; Hsu YJ; Yu YL; Chiang JM; Hsieh PS; Yeh CY; You JF
    Curr Oncol; 2022 May; 29(5):3708-3727. PubMed ID: 35621687
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DNA Repair Protein Expression and Oxidative/Nitrosative Stress in Ulcerative Colitis and Sporadic colorectal cancer.
    DE Angelis PM; Dorg L; Pham S; Andersen SN
    Anticancer Res; 2021 Jul; 41(7):3261-3270. PubMed ID: 34230120
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer.
    Li YK; Xu Q; Sun LP; Gong YH; Jing JJ; Xing CZ; Yuan Y
    World J Gastroenterol; 2020 Jan; 26(3):307-323. PubMed ID: 31988591
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of single-nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD-12/PRODIGE-2 phase III trial.
    Boige V; Mollevi C; Gourgou S; Azria D; Seitz JF; Vincent M; Bigot L; Juzyna B; Miran I; Gerard JP; Laurent-Puig P
    Int J Cancer; 2019 Dec; 145(11):3163-3172. PubMed ID: 31107542
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Bulky DNA adduct levels in normal-appearing colon mucosa, and the prevalence of colorectal adenomas.
    Ho V; Peacock S; Massey TE; Godschalk RW; van Schooten FJ; Ashbury JE; Vanner SJ; King WD
    Biomarkers; 2018 Dec; 23(8):735-741. PubMed ID: 29871536
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. DNA repair protein xpa is differentially expressed in colorectal cancer and predicts better prognosis.
    Feng X; Liu J; Gong Y; Gou K; Yang H; Yuan Y; Xing C
    Cancer Med; 2018 Jun; 7(6):2339-2349. PubMed ID: 29675892
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Differential Expression of Core Genes in Nucleotide Excision Repair Pathway Indicates colorectal Carcinogenesis and Prognosis.
    Liu J; Li H; Sun L; Feng X; Wang Z; Yuan Y; Xing C
    Biomed Res Int; 2018; 2018():9651320. PubMed ID: 29568775
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
    Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
    Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Functional, genetic, and epigenetic aspects of base and nucleotide excision repair in colorectal carcinomas.
    Slyskova J; Korenkova V; Collins AR; Prochazka P; Vodickova L; Svec J; Lipska L; Levy M; Schneiderova M; Liska V; Holubec L; Kumar R; Soucek P; Naccarati A; Vodicka P
    Clin Cancer Res; 2012 Nov; 18(21):5878-87. PubMed ID: 22966016
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. xpa A23G polymorphism and susceptibility to cancer: a meta-analysis.
    Liu J; Zhang Z; Cao XL; Lei DP; Wang ZQ; Jin T; Pan XL
    Mol Biol Rep; 2012 Jun; 39(6):6791-9. PubMed ID: 22314912
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls.
    Slyskova J; Naccarati A; Pardini B; Polakova V; Vodickova L; Smerhovsky Z; Levy M; Lipska L; Liska V; Vodicka P
    Mutagenesis; 2012 Mar; 27(2):225-32. PubMed ID: 22294771
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22.
    Abulí A; Fernández-Rozadilla C; Giráldez MD; Muñoz J; Gonzalo V; Bessa X; Bujanda L; Reñé JM; Lanas A; García AM; Saló J; Argüello L; Vilella A; Carreño R; Jover R; Xicola RM; Llor X; Carvajal-Carmona L; Tomlinson IP; Kerr DJ; Houlston RS; Piqué JM; Carracedo A; Castells A; Andreu M; Ruiz-Ponte C; Castellví-Bel S;
    Br J Cancer; 2011 Sep; 105(6):870-5. PubMed ID: 21811255
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer.
    Gil J; Ramsey D; Stembalska A; Karpinski P; Pesz KA; Laczmanska I; Leszczynski P; Grzebieniak Z; Sasiadek MM
    Mol Biol Rep; 2012 Jan; 39(1):527-34. PubMed ID: 21559836
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model: a resampling study.
    Marshall A; Altman DG; Holder RL
    BMC Med Res Methodol; 2010 Dec; 10():112. PubMed ID: 21194416
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population.
    Jelonek K; Gdowicz-Klosok A; Pietrowska M; Borkowska M; Korfanty J; Rzeszowska-Wolny J; Widlak P
    J Appl Genet; 2010; 51(3):343-52. PubMed ID: 20720310
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk.
    Joshi AD; Corral R; Siegmund KD; Haile RW; Le Marchand L; Martínez ME; Ahnen DJ; Sandler RS; Lance P; Stern MC
    Carcinogenesis; 2009 Mar; 30(3):472-9. PubMed ID: 19029193
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Single nucleotide polymorphisms in nucleotide excision repair genes xpa, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
    Monzo M; Moreno I; Navarro A; Ibeas R; Artells R; Gel B; Martinez F; Moreno J; Hernandez R; Navarro-Vigo M
    Oncology; 2007; 72(5-6):364-70. PubMed ID: 18204222
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. xpa A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
    Hansen RD; Sørensen M; Tjønneland A; Overvad K; Wallin H; Raaschou-Nielsen O; Vogel U
    Mutat Res; 2007 Jun; 619(1-2):68-80. PubMed ID: 17363013
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DNA repair pathway profiling and microsatellite instability in colorectal cancer.
    Yu J; Mallon MA; Zhang W; Freimuth RR; Marsh S; Watson MA; Goodfellow PJ; McLeod HL
    Clin Cancer Res; 2006 Sep; 12(17):5104-11. PubMed ID: 16951227
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?
    Aretz S; Koch A; Uhlhaas S; Friedl W; Propping P; von Schweinitz D; Pietsch T
    Pediatr Blood Cancer; 2006 Nov; 47(6):811-8. PubMed ID: 16317745
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.